NeoStem (NBS) Stock Plummets Today on Disappointing Cardiac Stem-Cell … – TheStreet.com
Bidness ETC |
NeoStem (NBS) Stock Plummets Today on Disappointing Cardiac Stem–Cell …
TheStreet.com The stem–cell therapy comes from a patient's own bone marrow and is injected into patients after a heart attack. The stem cells are then supposed to help blood flow and build cardiac muscle. NeoStem's trial used non-invasive imaging to monitor blood … Why NeoStem (NBS) Stock Might Decline Today NeoStem Announces Initial Positive Data from Phase 2 PreSERVE AMI Clinical … |
